NCT02731664View on ClinicalTrials.gov

GLP-1 Inhibits Prandial Antro-duodeno-jejunal Motility in Humans

PHASE1CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

September 30, 2012

Primary Completion Date

August 31, 2017

Study Completion Date

August 31, 2017

Conditions
Functional Gastrointestinal Disorders
Interventions
BIOLOGICAL

GLP-1

Intravenous infusion of GLP-1

BIOLOGICAL

Intravenous saline

Control

Trial Locations (1)

75185

Uppsala University, Uppsala

All Listed Sponsors
collaborator

Karolinska Institutet

OTHER

lead

Uppsala University

OTHER

NCT02731664 - GLP-1 Inhibits Prandial Antro-duodeno-jejunal Motility in Humans | Biotech Hunter | Biotech Hunter